ClinicalTrials.gg
Not yet recruitingNCT07879118OT-SMIUpdated Oct 16, 2026

Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness

An interventional study of Occupational Therapy Group Intervention in Schizophenia Disorder, Severe Mental Illness and Bipolar Disorder, sponsored by Biruni University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Biruni University · Not applicable, Interventional, and Treatment

Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Severe mental illness (SMI), including schizophrenia spectrum disorders and bipolar disorder, is associated with significant impairments in psychosocial functioning, daily life participation, self-efficacy, and social functioning. Despite pharmacological treatment, many individuals continue to experience limitations in social relationships, occupational roles, independent living activities, and overall functioning. Psychosocial rehabilitation interventions are therefore important components of comprehensive mental health care.

Occupational therapy aims to improve individuals' participation in meaningful daily activities, enhance occupational performance, strengthen social roles, and support recovery. However, evidence regarding the effects of occupational therapy interventions on internalized stigma, self-efficacy, and personal and social functioning among individuals with SMI remains limited.

This randomized controlled trial aims to investigate the effects of a structured occupational therapy group intervention on internalized stigma, self-efficacy, personal and social functioning, occupational performance, and instrumental activities of daily living in individuals with SMI receiving services at a Community Mental Health Center. Eligible participants will be randomly assigned to either an intervention group or a control group. The intervention group will participate in a seven-session occupational therapy group program, with one 60-90-minute session per week, while the control group will continue to receive routine Community Mental Health Center services.

The intervention addresses self-awareness and identity, internalized stigma, personal strengths and self-efficacy, daily life roles, role performance, goal setting, and social participation through structured group activities and psychoeducational components. Outcomes will be assessed before the intervention and after the seven-week intervention period using validated measures of internalized stigma, self-efficacy, personal and social functioning, occupational performance and satisfaction, and instrumental activities of daily living.

It is hypothesized that participants receiving the occupational therapy intervention will demonstrate reduced internalized stigma and improved self-efficacy and personal and social functioning compared with participants receiving routine services alone.

02

Conditions studied

  • Schizophenia Disorder
  • Severe Mental Illness
  • Bipolar Disorder
  • Nonorganic Psychosis
  • Schizo-affective Disorder
03

In context

Mental Disorders

2,148 studies on the registry are indexed under Mental Disorders; 425 are open to participants now.

This study's planned enrollment of 50 is below the median of 96 across 1,607 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Biruni University is the lead sponsor of 179 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Registered at the Community Mental Health Center (CMHC).
  • Diagnosis of schizophrenia, schizoaffective disorder, non-organic psychosis, or bipolar disorder according to DSM-5 criteria, confirmed by the psychiatrist responsible for the CMHC.
  • Aged between 18 and 65 years.
  • In remission, as confirmed by the psychiatrist responsible for the CMHC.
  • Able to read and write.
  • Willing to participate in the study and provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Being in an acute psychotic exacerbation.
  • Presence of a severe neurological disorder or a medical condition that would prevent participation in the intervention.
  • Presence of cognitive impairment or intellectual disability that would prevent participation in the study.
  • Presence of language or speech problems that would prevent participation in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Occupational Therapy Intervention Group

    Participants in this group will receive a structured seven-session occupational therapy group intervention in addition to routine Community Mental Health Center services. Sessions will be delivered once weekly for 60-90 minutes over seven weeks.

    Behavioral: Occupational Therapy Group Intervention

  • No intervention
    Control Group

    Participants in this group will continue to receive routine Community Mental Health Center services and will not receive any additional occupational therapy intervention during the seven-week study period.

Interventions

  • BehavioralOccupational Therapy Group Intervention

    A structured occupational therapy group intervention consisting of seven weekly sessions, each lasting approximately 60-90 minutes. The program addresses self-awareness and identity, internalized stigma, personal strengths and self-efficacy, daily life roles, role performance, goal setting, and social participation through structured group activities and psychoeducational components.

06

What researchers measure

Primary outcomes

  1. Change in Internalized Stigma of Mental Illness Scale (ISMI) Score

    Internalized stigma will be assessed using the Internalized Stigma of Mental Illness Scale (ISMI). The scale consists of 29 items rated on a 4-point Likert scale. Total scores range from 29 to 116, with higher scores indicating higher levels of internalized stigma.

    Time frame: Baseline and immediately after the 7-week intervention.

  2. Change in General Self-Efficacy Scale Score

    Self-efficacy will be assessed using the 17-item General Self-Efficacy Scale. Total scores range from 17 to 85, with higher scores indicating greater self-efficacy.

    Time frame: Baseline and immediately after the 7-week intervention.

  3. Change in Personal and Social Performance Scale (PSP) Score

    Personal and social functioning will be assessed using the Personal and Social Performance Scale. The overall score ranges from 1 to 100, with higher scores indicating better personal and social functioning.

    Time frame: Baseline and immediately after the 7-week intervention.

  4. Change in Canadian Occupational Performance Measure (COPM) Scores

    Occupational performance will be assessed using the Canadian Occupational Performance Measure (COPM). Participants identify and prioritize occupational performance problems and rate their perceived performance on a 10-point scale, with higher scores indicating better perceived occupational performance. Change in occupational performance from baseline to post-intervention will be evaluated.

    Time frame: Baseline and immediately after the 7-week intervention.

  5. Change in Lawton-Brody Instrumental Activities of Daily Living (IADL) Score

    Independence in instrumental activities of daily living will be assessed using the Lawton-Brody Instrumental Activities of Daily Living Scale. Total scores range from 0 to 8, with higher scores indicating greater independence.

    Time frame: Baseline and immediately after the 7-week intervention.

07

Study locations

1 site
  • Çekmeköy Toplum Ruh Sağlığı Merkezi
    Istanbul, Istanbul 34782, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07879118
Lead sponsor
Biruni University
Responsible party
Sponsor
First posted
Oct 16, 2026
Start date
Oct 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 16, 2026

Study contacts

Şüheda Keleş Özen, BSc
Contact
suheda.keles@std.medipol.edu.tr
+90 545 554 09 18
Eylül Pınar Kısa, PhD
principal investigator · Medipol University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion